3/11
07:21 am
cdna
CareDx Launches Two Expanded Indications for AlloSure Testing Services [Yahoo! Finance]
Low
Report
CareDx Launches Two Expanded Indications for AlloSure Testing Services [Yahoo! Finance]
3/11
07:05 am
cdna
CareDx Launches Two Expanded Indications for AlloSure Testing Services
Low
Report
CareDx Launches Two Expanded Indications for AlloSure Testing Services
3/7
06:16 am
cdna
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position [Yahoo! Finance]
Low
Report
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position [Yahoo! Finance]
3/4
02:50 pm
cdna
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
Neutral
Report
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
3/3
08:10 am
cdna
CareDx, Inc (NASDAQ: CDNA) had its price target lowered by analysts at HC Wainwright from $26.00 to $25.00. They now have a "neutral" rating on the stock.
Medium
Report
CareDx, Inc (NASDAQ: CDNA) had its price target lowered by analysts at HC Wainwright from $26.00 to $25.00. They now have a "neutral" rating on the stock.
2/27
09:51 am
cdna
CareDx, Inc (NASDAQ: CDNA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $40.00 price target on the stock.
Medium
Report
CareDx, Inc (NASDAQ: CDNA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $40.00 price target on the stock.
2/26
09:07 pm
cdna
CareDx (CDNA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Low
Report
CareDx (CDNA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
2/26
04:36 pm
cdna
CareDx Announces Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
Low
Report
CareDx Announces Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
2/26
04:05 pm
cdna
CareDx Announces Fourth Quarter and Full Year 2024 Financial Results
Low
Report
CareDx Announces Fourth Quarter and Full Year 2024 Financial Results
2/26
02:08 am
cdna
CareDx, Inc (NASDAQ: CDNA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
CareDx, Inc (NASDAQ: CDNA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/25
10:52 am
cdna
CareDx Inc (CDNA) Q4 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Medium
Report
CareDx Inc (CDNA) Q4 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
2/25
07:23 am
cdna
CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict [Yahoo! Finance]
Medium
Report
CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict [Yahoo! Finance]
2/25
07:05 am
cdna
CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict
Medium
Report
CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict
2/21
09:43 am
cdna
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
Medium
Report
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
2/20
07:37 am
cdna
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients [Yahoo! Finance]
Medium
Report
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients [Yahoo! Finance]
2/20
07:05 am
cdna
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients
Medium
Report
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients
2/18
11:08 pm
cdna
CareDx, Inc (NASDAQ: CDNA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
CareDx, Inc (NASDAQ: CDNA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
2/13
07:44 am
cdna
CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies [Yahoo! Finance]
Medium
Report
CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies [Yahoo! Finance]
2/13
07:05 am
cdna
CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies
Medium
Report
CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies
2/11
07:38 am
cdna
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
Medium
Report
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
2/11
07:05 am
cdna
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results
Medium
Report
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results
1/21
10:31 am
cdna
New Strong Buy Stocks for January 21st [Yahoo! Finance]
Low
Report
New Strong Buy Stocks for January 21st [Yahoo! Finance]
1/15
06:39 am
cdna
CareDx, Inc (NASDAQ: CDNA) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $24.00 price target on the stock, down previously from $28.00.
Low
Report
CareDx, Inc (NASDAQ: CDNA) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $24.00 price target on the stock, down previously from $28.00.
1/14
08:02 am
cdna
CareDx, Inc (NASDAQ: CDNA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $26.00 price target on the stock.
Medium
Report
CareDx, Inc (NASDAQ: CDNA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $26.00 price target on the stock.
1/13
07:00 am
cdna
CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results
Low
Report
CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results